Brief: Paxmedica Featured In Syndicated Broadcast Highlighting FDA Type-B Meeting To Review Pax-101
17/11/2023 14:18
Nov 17 (Reuters) - PaxMedica Inc PXMD.O :
* PAXMEDICA INC. FEATURED IN SYNDICATED BROADCAST
HIGHLIGHTING FDA
TYPE-B MEETING TO REVIEW PAX-101 PIVOTAL TRIAL DATA
Source text for Eikon: ID:nGNX2z9Ysn
Further company coverage: PXMD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kuvatris Therapeutics
See all newsBrief: PaxMedica Responds To Emergency Request For IV Suramin And Commits To Provide Immediate Access To PAX-101
PaxMedica rises on Malawi's request for access to sleeping sickness drug
Brief: Paxmedica Receives Emergency Request For Iv Suramin From African Health Ministry For Use In Treating Fatal Sleeping Sickness
Brief: PaxMedica Achieves Key Milestone In The Development Of PAX-101 And Provides Update On Potential NDA Submission
Brief: Paxmedica Announces Pricing Of $7.0 Million Public Offering